Related references
Note: Only part of the references are listed.Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Pancreas cancer: Therapeutic trials in metastatic disease
James W. Smithy et al.
JOURNAL OF SURGICAL ONCOLOGY (2021)
The Future of Clinical Trial Design in Oncology
Anna Spreafico et al.
CANCER DISCOVERY (2021)
Silencing of CHFR Sensitizes Gastric Carcinoma to PARP Inhibitor Treatment
Yuan Li et al.
TRANSLATIONAL ONCOLOGY (2020)
Analysis of the methylation of CpG islands in the CDO1, TAC1 and CHFR genes in pancreatic ductal cancer
Hiroshi Maekawa et al.
ONCOLOGY LETTERS (2020)
Five gene signatures were identified in the prediction of overall survival in resectable pancreatic cancer
Chao Wu et al.
BMC SURGERY (2020)
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
Talia Golan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Association of CHFR Promoter Methylation with Treatment Outcomes of Irinotecan-Based Chemotherapy in Metastatic Colorectal Cancer
Yongjun Cha et al.
NEOPLASIA (2019)
CHFR Promoter Hypermethylation Is Associated with Gastric Cancer and Plays a Protective Role in Gastric Cancer Process
Dongjun Dai et al.
JOURNAL OF CANCER (2019)
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
Prashanth Rawla et al.
WORLD JOURNAL OF ONCOLOGY (2019)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Upregulation of the checkpoint protein CHFR is associated with tumor suppression in pancreatic cancers
Di Zhang et al.
ONCOLOGY LETTERS (2017)
Clinicopathological significance of CHFR promoter methylation in gastric cancer: a meta-analysis
Yong Ding et al.
Oncotarget (2017)
Association between CHFR gene hypermethylation and gastric cancer risk: a meta-analysis
Hua Shi et al.
ONCOTARGETS AND THERAPY (2016)
Small molecule inhibition of the CHFR-PARP1 interaction as novel approach to overcome intrinsic taxane resistance in cancer
Seth A. Brodie et al.
ONCOTARGET (2015)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
CHFR silencing or microsatellite instability is associated with increased antitumor activity of docetaxel or gemcitabine in colorectal cancer
Lorraine Pelosof et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
CHFR Protein Expression Predicts Outcomes to Taxane-Based First Line Therapy in Metastatic NSCLC
Rathi N. Pillai et al.
CLINICAL CANCER RESEARCH (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
CHFR: a key checkpoint component implicated in a wide range of cancers
Sheru Sanbhnani et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Association of CHFR Promoter Methylation with Disease Recurrence in Locally Advanced Colon Cancer
Motofumi Tanaka et al.
CLINICAL CANCER RESEARCH (2011)
Alternative efficacy-predicting markers for paclitaxel instead of CHFR in non-small cell lung cancer
Masafumi Takeshita et al.
CANCER BIOLOGY & THERAPY (2010)
Safeguarding Entry into Mitosis: the Antephase Checkpoint
Cheen Fei Chin et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Shared and separate functions of polo-like kinases and aurora kinases in cancer
Susanne M. A. Lens et al.
NATURE REVIEWS CANCER (2010)
Deficiencies in Chfr and Mlh1 synergistically enhance tumor susceptibility in mice
Zheng Fu et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Chfr is linked to tumour metastasis through the downregulation of HDAC1
Young Mi Oh et al.
NATURE CELL BIOLOGY (2009)
The Aurora kinase family in cell division and cancer
Gerben Vader et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2008)
Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins
Ivan Ahel et al.
NATURE (2008)
Structure and Function of the Phosphothreonine-Specific FHA Domain
Anjali Mahajan et al.
SCIENCE SIGNALING (2008)
Molecular analysis of primary gastric cancer, corresponding xenografts, and 2 novel gastric carcinoma cell lines reveals novel alterations in gastric carcinogenesis
Anya N. A. Milne et al.
HUMAN PATHOLOGY (2007)
The significance of aberrant CHFR methylation for clinical response to microtubule inhibitors in gastric cancer
Y Koga et al.
JOURNAL OF GASTROENTEROLOGY (2006)
CHFR promoter hypermethylation in colon cancer correlates with the microsatellite instability phenotype
JC Brandes et al.
CARCINOGENESIS (2005)
Chfr is required for tumor suppression and Aurora A regulation
XC Yu et al.
NATURE GENETICS (2005)
Chfr inactivation is not associated to chromosomal instability in colon cancers
J Bertholon et al.
ONCOGENE (2003)
The checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition
DM Kang et al.
JOURNAL OF CELL BIOLOGY (2002)
Chfr defines a mitotic stress checkpoint that delays entry into metaphase
DM Scolnick et al.
NATURE (2000)
Share Paper
